vs

Side-by-side financial comparison of Broadway Financial Corp (BYFC) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $9.4M, roughly 1.4× Broadway Financial Corp). Broadway Financial Corp runs the higher net margin — 1934.0% vs -488.0%, a 2421.9% gap on every dollar of revenue. On growth, Broadway Financial Corp posted the faster year-over-year revenue change (10.1% vs -22.4%). Broadway Financial Corp produced more free cash flow last quarter ($-13.0K vs $-57.1M). Over the past eight quarters, Broadway Financial Corp's revenue compounded faster (9.7% CAGR vs -5.3%).

Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

BYFC vs OCUL — Head-to-Head

Bigger by revenue
OCUL
OCUL
1.4× larger
OCUL
$13.3M
$9.4M
BYFC
Growing faster (revenue YoY)
BYFC
BYFC
+32.5% gap
BYFC
10.1%
-22.4%
OCUL
Higher net margin
BYFC
BYFC
2421.9% more per $
BYFC
1934.0%
-488.0%
OCUL
More free cash flow
BYFC
BYFC
$57.1M more FCF
BYFC
$-13.0K
$-57.1M
OCUL
Faster 2-yr revenue CAGR
BYFC
BYFC
Annualised
BYFC
9.7%
-5.3%
OCUL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BYFC
BYFC
OCUL
OCUL
Revenue
$9.4M
$13.3M
Net Profit
$1.0M
$-64.7M
Gross Margin
88.0%
Operating Margin
-526.5%
Net Margin
1934.0%
-488.0%
Revenue YoY
10.1%
-22.4%
Net Profit YoY
-21.8%
-33.6%
EPS (diluted)
$0.02
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BYFC
BYFC
OCUL
OCUL
Q4 25
$9.4M
$13.3M
Q3 25
$9.0M
$14.5M
Q2 25
$8.1M
$13.5M
Q1 25
$8.3M
$10.7M
Q4 24
$8.6M
$17.1M
Q3 24
$8.7M
$15.4M
Q2 24
$8.2M
$16.4M
Q1 24
$7.8M
$14.8M
Net Profit
BYFC
BYFC
OCUL
OCUL
Q4 25
$1.0M
$-64.7M
Q3 25
$-23.9M
$-69.4M
Q2 25
$752.0K
$-67.8M
Q1 25
$-2.7M
$-64.1M
Q4 24
$1.3M
$-48.4M
Q3 24
$516.0K
$-36.5M
Q2 24
$256.0K
$-43.8M
Q1 24
$-154.0K
$-64.8M
Gross Margin
BYFC
BYFC
OCUL
OCUL
Q4 25
88.0%
Q3 25
87.8%
Q2 25
85.6%
Q1 25
88.2%
Q4 24
92.8%
Q3 24
89.9%
Q2 24
90.8%
Q1 24
91.0%
Operating Margin
BYFC
BYFC
OCUL
OCUL
Q4 25
-526.5%
Q3 25
-256.2%
-472.3%
Q2 25
12.8%
-502.6%
Q1 25
-45.3%
-597.5%
Q4 24
21.7%
-296.1%
Q3 24
8.5%
-298.2%
Q2 24
4.8%
-265.1%
Q1 24
-2.9%
-214.0%
Net Margin
BYFC
BYFC
OCUL
OCUL
Q4 25
1934.0%
-488.0%
Q3 25
-264.2%
-477.3%
Q2 25
9.3%
-503.9%
Q1 25
-32.3%
-598.7%
Q4 24
15.3%
-283.3%
Q3 24
5.9%
-236.6%
Q2 24
3.1%
-266.3%
Q1 24
-2.0%
-438.9%
EPS (diluted)
BYFC
BYFC
OCUL
OCUL
Q4 25
$0.02
$-0.27
Q3 25
$-2.86
$-0.38
Q2 25
$0.00
$-0.39
Q1 25
$-0.39
$-0.38
Q4 24
$0.07
$-0.25
Q3 24
$-0.03
$-0.22
Q2 24
$0.02
$-0.26
Q1 24
$-0.02
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BYFC
BYFC
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$10.5M
$737.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$262.8M
$654.3M
Total Assets
$1.3B
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BYFC
BYFC
OCUL
OCUL
Q4 25
$10.5M
$737.1M
Q3 25
$19.7M
$344.8M
Q2 25
$29.5M
$391.1M
Q1 25
$15.8M
$349.7M
Q4 24
$61.4M
$392.1M
Q3 24
$97.1M
$427.2M
Q2 24
$89.8M
$459.7M
Q1 24
$67.1M
$482.9M
Stockholders' Equity
BYFC
BYFC
OCUL
OCUL
Q4 25
$262.8M
$654.3M
Q3 25
$261.7M
$258.2M
Q2 25
$284.7M
$305.9M
Q1 25
$283.6M
$265.9M
Q4 24
$285.0M
$315.3M
Q3 24
$286.2M
$352.0M
Q2 24
$282.1M
$377.7M
Q1 24
$281.1M
$408.0M
Total Assets
BYFC
BYFC
OCUL
OCUL
Q4 25
$1.3B
$808.1M
Q3 25
$1.3B
$410.9M
Q2 25
$1.2B
$451.3M
Q1 25
$1.3B
$405.9M
Q4 24
$1.3B
$457.9M
Q3 24
$1.4B
$490.4M
Q2 24
$1.4B
$517.1M
Q1 24
$1.4B
$538.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BYFC
BYFC
OCUL
OCUL
Operating Cash FlowLast quarter
$230.0K
$-54.2M
Free Cash FlowOCF − Capex
$-13.0K
$-57.1M
FCF MarginFCF / Revenue
-0.1%
-430.9%
Capex IntensityCapex / Revenue
2.6%
21.4%
Cash ConversionOCF / Net Profit
0.22×
TTM Free Cash FlowTrailing 4 quarters
$2.3M
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BYFC
BYFC
OCUL
OCUL
Q4 25
$230.0K
$-54.2M
Q3 25
$3.8M
$-50.7M
Q2 25
$3.0M
$-55.2M
Q1 25
$-4.3M
$-44.7M
Q4 24
$1.4M
$-39.4M
Q3 24
$6.1M
$-36.6M
Q2 24
$9.8M
$-24.8M
Q1 24
$-11.7M
$-33.9M
Free Cash Flow
BYFC
BYFC
OCUL
OCUL
Q4 25
$-13.0K
$-57.1M
Q3 25
$3.7M
$-56.7M
Q2 25
$3.0M
$-56.5M
Q1 25
$-4.4M
$-46.6M
Q4 24
$1.3M
$-39.6M
Q3 24
$6.1M
$-36.6M
Q2 24
$9.7M
$-25.5M
Q1 24
$-11.7M
$-34.1M
FCF Margin
BYFC
BYFC
OCUL
OCUL
Q4 25
-0.1%
-430.9%
Q3 25
41.1%
-390.0%
Q2 25
37.0%
-419.7%
Q1 25
-52.4%
-435.6%
Q4 24
14.7%
-232.0%
Q3 24
69.6%
-237.6%
Q2 24
118.9%
-155.4%
Q1 24
-149.7%
-231.1%
Capex Intensity
BYFC
BYFC
OCUL
OCUL
Q4 25
2.6%
21.4%
Q3 25
1.2%
41.2%
Q2 25
0.2%
9.3%
Q1 25
0.2%
18.1%
Q4 24
1.6%
1.2%
Q3 24
0.3%
0.6%
Q2 24
0.5%
4.5%
Q1 24
0.7%
1.7%
Cash Conversion
BYFC
BYFC
OCUL
OCUL
Q4 25
0.22×
Q3 25
Q2 25
4.00×
Q1 25
Q4 24
1.06×
Q3 24
11.85×
Q2 24
38.21×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons